Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,21,0.98 [0.87-1.10],0.69743159570369
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,21,0.95 [0.87-1.05],0.353723867765524
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,21,1.27 [0.74-2.18],0.384625435813714
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,21,0.88 [0.69-1.12],0.31440058302627
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,21,1.21 [1.09-1.34],0.0002536018971668
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,21,1.04 [0.80-1.35],0.789407674273119
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,21,1.17 [0.89-1.55],0.263962280951277
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,21,1.76 [1.29-2.40],0.0003610350778952
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,21,1.25 [1.05-1.48],0.0110833954993183
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,21,1.85 [1.35-2.53],0.0001318759424074
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,21,1.54 [1.23-1.93],0.000137990695587
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,21,1.05 [0.48-2.32],0.900660033436466
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,21,1.17 [0.94-1.46],0.161179747614214
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,21,0.99 [0.94-1.04],0.587184697480482
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,21,1.03 [0.96-1.09],0.439955665671847
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,21,1.11 [0.97-1.27],0.144312126512023
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,21,1.44 [1.18-1.76],0.0002932687203466
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,21,0.99 [0.88-1.11],0.813966380081776
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,21,1.05 [0.95-1.16],0.307286508387364
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,21,1.26 [1.06-1.49],0.008542908137221
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,21,1.01 [0.95-1.08],0.69628599144995
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,21,1.02 [0.97-1.08],0.424109667093971
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,21,0.77 [0.56-1.04],0.092064881951673
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,21,1.20 [1.08-1.33],0.0006594104277434
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,21,1.03 [0.80-1.33],0.809197771920812
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,21,0.97 [0.79-1.19],0.751389218003369
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,21,1.10 [0.97-1.24],0.145231619969995
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,21,1.02 [0.92-1.13],0.685973135543522
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,21,1.24 [1.02-1.51],0.0332529978851838
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,21,0.93 [0.83-1.04],0.19429737694718
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,21,1.01 [0.89-1.15],0.898442107427516
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,21,0.93 [0.83-1.04],0.201920991896485
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,21,0.95 [0.78-1.16],0.626530303470888
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,21,0.96 [0.91-1.02],0.189133145482908
